Nitrosamines are unintended but potentially harmful impurities that can emerge during the manufacturing of pharmaceuticals. Recognized for their carcinogenic potential, the detection and control of these impurities are critical for ensuring drug safety. Recent advancements in analytical technologies have greatly enhanced the pharmaceutical industry’s ability to identify and mitigate the risks posed by nitrosamines, leading […]
Related Articles
This post first appeared on Leading Pharmaceutical Industry Online Platform, please read the originial post: here